Saving Lives and Livelihoods | Mastercard Foundation

Saving Lives and Livelihoods

A bold partnership with Africa CDC to strengthen African public health systems.

Dr. Maryanne Wanjiru standing in the KAVI Institute of Clinical Research, University of Nairobi. Dr. Robert Langat at the KAVI Institute of Clinical Research, University of Nairobi. Two healthcare workers collaborating at work

Saving Lives and Livelihoods is ensuring vaccine equity for Africa, supporting the delivery of vaccinations to millions more, and integrating into and supporting the delivery of routine immunization.

The Saving Lives and Livelihoods (SLL) initiative assures the continent's long-term health security by developing the workforce for vaccine manufacturing in Africa and strengthening Africa CDC. This partnership is an enabler of and a contributor to the Foundation’s Young Africa Works strategy, which seeks to enable 30 million young people, particularly young women, to access dignified and fulfilling work by 2030.

A young woman in PPE working in a laboratory
Dr. Maryanne Wanjiru – KAVI Institute of Clinical Research, University of Nairobi

Saving Lives and Livelihoods has had a profound impact in safeguarding the health of millions of people across Africa.

SLL Impact Summary of Phase I

  • 50%

    Vaccine coverage increased from 3% to 50% of the target population.

  • 44M

    Secured approximately 44 million vaccines for member states.

  • 32

    Established vaccination centres and procured cold chain equipment for 32 countries.

  • 38K

    Trained workers, equipped, and deployed nearly 38,000 health workers and created over 23,000 new jobs.

  • 47

    Expanded laboratory capacity from very few to 47 facilities capable of genomic sequencing.

  • 99

    Advanced knowledge production and management efforts skilled 99 professionals across 15 member states and produced 58 technical reports.

Phase 2 emphasizes strengthening Africa's capacity to respond to future pandemics by supporting program activities that reinforce the health workforce and improve livelihoods.

SLL Impact Summary of Phase II

  • 200M

    When fully operational the Manufacturing in Africa for Disease Immunization and Building Autonomy (MADIBA) vaccine manufacturing plant will produce over 200 million vaccine doses per year.

  • 800

    Equipping Institute Pasteur Dakar’s (IPD) Regional Training Hub to provide experiential training in biomanufacturing for over 800 health and technical professionals annually.

  • 11.2M

    Delivery of over 11.2 million vaccine doses, and 13.7 million units of ancillaries and PPE.

  • 36K

    Provision delivery of integrated vaccination services to approximately 36,000 people (55% women, 51% young people).

  • 18

    Procurement and installation of Cold Chain Equipment in 18 Member States.

  • 12K

    Over 12,000 health workers have been trained across all partners for integrated immunization services, pharmacovigilance, in country logistics support, and laboratory strengthening (76% young people, 48% women).

Status

active

Period

2021–2025

Countries

Focus Areas